Wayne Embree is listed as an executive officer and director on 19 SEC Form D filings by 10 issuers between Aug 2013 and Aug 2026. Largest by amount reported sold: Clarametyx Biosciences, Inc. (Columbus, OH — biotechnology — 2024; $27.5M reported sold to 7 investors), Invirsa, Inc. (Columbus, OH — pharmaceuticals — 2022–2025; $5.98M reported sold to 14 investors), Traycer Diagnostic Systems, Inc. (South San Francisco, CA — other technology — 2013; $4.78M reported sold to 9 investors), Catalyst Fund V, LLC (Columbus, OH — pooled investment fund — 2014; $3.5M reported sold to 3 investors), Ohio TechAngel Fund V, LLC (Columbus, OH — pooled investment fund — 2016; $2.6M reported sold to 48 investors) and 5 more (all listed below).
What this means That is a lot of deals — 10 separate companies raised money with this person listed as executive officer and director, over about 13 years. Across those companies the filings report $49.5M sold in total.
Listed alongside Donald Caudy (4 shared filings), Fabio Chiara (4 shared filings), Faith Voinovich (4 shared filings), Robert D. Underhill (4 shared filings), Robert Shalwitz (4 shared filings) and 42 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Wayne. Each name links to their own page.
2 of the issuers belong to the sponsor group Ocudoc (4 issuers, $6.76M reported sold, 2016–2024).
What this means A sponsor group is one team that sets up a new company for each deal. Ocudoc has 4 companies on file and $6.76M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 19 public filings for Wayne Embree and found 13 differences, 4 worth asking the sponsor about: Investor count went down between filings; 5 filings report more than 10% of the money raised going to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.